FRANCESCHINI, Erica
 Distribuzione geografica
Continente #
NA - Nord America 10.856
AS - Asia 6.480
EU - Europa 6.215
SA - Sud America 947
AF - Africa 170
OC - Oceania 21
Continente sconosciuto - Info sul continente non disponibili 7
AN - Antartide 1
Totale 24.697
Nazione #
US - Stati Uniti d'America 10.471
IT - Italia 2.285
SG - Singapore 1.922
CN - Cina 1.520
GB - Regno Unito 1.246
VN - Vietnam 791
HK - Hong Kong 704
BR - Brasile 675
DE - Germania 611
BD - Bangladesh 504
SE - Svezia 438
RU - Federazione Russa 340
FI - Finlandia 295
FR - Francia 278
CA - Canada 242
KR - Corea 205
ID - Indonesia 160
IN - India 145
NL - Olanda 134
TR - Turchia 107
AR - Argentina 94
UA - Ucraina 77
MX - Messico 76
BG - Bulgaria 71
ES - Italia 71
JP - Giappone 66
PL - Polonia 56
LT - Lituania 53
IQ - Iraq 50
ZA - Sudafrica 45
CO - Colombia 44
PK - Pakistan 39
AE - Emirati Arabi Uniti 38
IE - Irlanda 33
AT - Austria 31
EC - Ecuador 30
SI - Slovenia 29
CL - Cile 28
CZ - Repubblica Ceca 28
MA - Marocco 28
BE - Belgio 26
VE - Venezuela 24
CH - Svizzera 20
IL - Israele 20
MY - Malesia 20
AU - Australia 18
IR - Iran 18
PY - Paraguay 18
UZ - Uzbekistan 18
EG - Egitto 17
NP - Nepal 17
PE - Perù 17
SA - Arabia Saudita 16
PH - Filippine 15
CR - Costa Rica 13
JO - Giordania 12
TH - Thailandia 12
TN - Tunisia 12
TW - Taiwan 12
KE - Kenya 11
RO - Romania 11
AZ - Azerbaigian 10
DZ - Algeria 10
ET - Etiopia 9
GR - Grecia 9
KZ - Kazakistan 9
OM - Oman 9
SN - Senegal 9
BO - Bolivia 8
JM - Giamaica 8
PA - Panama 8
PT - Portogallo 8
GE - Georgia 7
HU - Ungheria 7
LV - Lettonia 7
NG - Nigeria 7
PR - Porto Rico 7
PS - Palestinian Territory 7
UY - Uruguay 7
DK - Danimarca 6
DO - Repubblica Dominicana 6
EE - Estonia 6
SK - Slovacchia (Repubblica Slovacca) 6
AL - Albania 5
GT - Guatemala 5
MK - Macedonia 5
TT - Trinidad e Tobago 5
BH - Bahrain 4
CI - Costa d'Avorio 4
MN - Mongolia 4
NO - Norvegia 4
RS - Serbia 4
SD - Sudan 4
SV - El Salvador 4
A2 - ???statistics.table.value.countryCode.A2??? 3
BA - Bosnia-Erzegovina 3
BY - Bielorussia 3
EU - Europa 3
HR - Croazia 3
KG - Kirghizistan 3
Totale 24.643
Città #
Ashburn 1.392
Singapore 1.205
Santa Clara 1.192
Southend 768
Fairfield 734
San Jose 679
Hong Kong 676
Chandler 575
Hefei 482
Houston 319
Seattle 313
Woodbridge 282
Nyköping 276
Los Angeles 269
London 257
New York 257
Council Bluffs 256
Beijing 242
Ho Chi Minh City 242
Cambridge 236
Wilmington 229
Helsinki 219
Dallas 211
Seoul 199
Milan 185
Modena 181
Hanoi 173
Munich 162
Chicago 152
Ann Arbor 151
Bologna 141
The Dalles 134
Rome 128
Jakarta 122
San Diego 122
Dearborn 98
Lauterbourg 98
Shanghai 89
Buffalo 82
Moscow 80
Toronto 78
Jacksonville 74
Princeton 64
Sofia 60
São Paulo 60
Orem 56
Frankfurt am Main 55
Parma 53
Tokyo 53
Naples 51
Warsaw 49
Bremen 46
Turku 45
Salt Lake City 44
Amsterdam 42
Atlanta 41
Izmir 40
Redwood City 40
Fremont 39
Montreal 39
Boardman 38
Da Nang 38
North York 37
Nuremberg 37
Phoenix 37
Reggio Emilia 37
Haiphong 36
Mexico City 33
Turin 32
Stockholm 31
Columbus 30
Hillsboro 30
Brooklyn 28
Johannesburg 28
Brussels 26
Dublin 26
Falls Church 26
Kent 26
Redondo Beach 26
Tampa 26
Palermo 24
Rimini 24
Chennai 23
Paris 23
San Francisco 23
Catania 22
Mumbai 22
Rio de Janeiro 22
Des Moines 21
Eugene 21
Florence 21
Guangzhou 20
Madrid 20
Verona 20
Bari 19
Miami 19
Poplar 19
Biên Hòa 18
Denver 18
Durham 18
Totale 15.682
Nome #
Multidrug-resistant tuberculosis outbreak in an Italian prison: Tolerance of pyrazinamide plus levofloxacin prophylaxis and serial interferon gamma release assays 806
COVID-19-associated vasculitis and thrombotic complications: from pathological findings to multidisciplinary discussion 518
Clinical Utility of Epstein-Barr Virus Viral Load Monitoring and Risk Factors for Posttransplant Lymphoproliferative Disorders After Kidney Transplantation 474
A five-component infection control bundle to permanently eliminate a carbapenem-resistant Acinetobacter baumannii spreading in an intensive care unit 474
Tocilizumab in patients with severe COVID-19: a retrospective cohort study 462
Efficient T cell compartment in HIV+ patients receiving orthotopic liver transplant and immunosuppressive therapy 444
Clinical outcome of kidney transplantation in HIV-infected recipients: a retrospective study 437
Epidemiology and clinical outcome of lower respiratory tract infections by respiratory syncytial virus or parainfluenza virus type 3 in adults receiving treatment for either acute leukemia or severe aplastic anemia: a retrospective single center study 423
A frailty index predicts post-liver transplant morbidity and mortality in HIV-positive patients 419
Metabolic reprograming shapes neutrophil functions in severe COVID-19 414
Better prognosis in females with severe COVID-19 pneumonia: possible role of inflammation as potential mediator. 379
Antimicrobial stewardship in a Gastroenterology Department: Impact on antimicrobial consumption, antimicrobial resistance and clinical outcome 376
Gastric Mucormycosis in a Liver and Kidney Transplant Recipient: Case Report and Concise Review of Literature 376
Machine learning in predicting respiratory failure in patients with COVID-19 pneumonia - challenges, strengths, and opportunities in a global health emergency. 372
Herpes Simplex re-activation in patients with SARS-CoV2 pneumonia: a prospective observational study. 370
Acute human herpes virus 7 (HHV-7) encephalitis in an immunocompetent adult patient: a case report and review of literature 369
Cytomegalovirus blood reactivation in COVID-19 critically ill patients: risk factors and impact on mortality. 369
Rhodococcus equi Pneumonia in Kidney Transplant Recipient Affected by Acute Intermittent Porphyria: A Case Report 368
First and second waves among hospitalised patients with COVID-19 with severe pneumonia: a comparison of 28-day mortality over the 1-year pandemic in a tertiary university hospital in Italy 338
Immunophenotypic Profile and Clinical Outcome of Monoclonal B-cell Lymphocytosis in Kidney Transplantation 331
Hypokalemia in Patients with COVID-19 329
Clinical and Microbiological Characteristics of Visceral Leishmaniasis Outbreak in a Northern Italian Nonendemic Area: A Retrospective Observational Study 322
Darunavir/Cobicistat Is Associated with Negative Outcomes in HIV-Negative Patients with Severe COVID-19 Pneumonia 320
Peritoneal dialysis in the time of coronavirus disease 2019 304
Aseptic Osteonecrosis: A Newly Diagnosed Complication in HIV-Infected Patients Undergoing Liver Transplantation. 293
The impact of tocilizumab on respiratory support states transition and clinical outcomes in COVID-19 patients. A Markov model multi-state study 292
Changing in the post-surgery infective complications following the shortening of the antibiotic prophylaxis in the patients undergoing skin dermal substitutes reconstruction 285
Epidemiology and clinical outcomes of latent tuberculosis infection in adults affected with acute leukemia or aplastic anemia: a retrospective single-center study 284
Antiviral activity of sirolimus in an HIV-positive kidney transplant recipient 273
INTRAVENOUS FOSFOMYCIN IN COMBINATION REGIMENS AS A TREATMENT OPTION FOR DIFFICULT-TO-TREAT INFECTIONS DUE TO MULTIDRUG-RESISTANT GRAM-NEGATIVE ORGANISMS: A REAL-LIFE EXPERIENCE 269
Epidemiology and Outcomes of Bloodstream Infections in HIV-Patients during a 13-Year Period 269
Engagement and retention in care of patients diagnosed with HIV infection and enrolled in the Modena HIV surveillance cohort. 268
Immunomodulation for the management of severe SARS-CoV2 infections. State of the art and review of the literature 267
Acid base disorders in patients with COVID-19 266
Infective complications in patients undergoing surgical reconstruction with dermal matrix: the Modena experience 264
Development and validation of a prediction model for tocilizumab failure in hospitalized patients with SARS-CoV-2 infection 261
Seven versus fourteen Days of Antibiotic Therapy for uncomplicated Gram-negative Bacteremia: a Non-inferiority Randomized Controlled Trial 256
Advances and Challenges in Sepsis Management: Modern Tools and Future Directions 256
Pneumocystosis as a Complication of H1N1 Influenza A Infection in an HIV-Positive Patient on Effective cART 255
A Fatal Case of Pseudomonas aeruginosa Community-Acquired Pneumonia in an Immunocompetent Patient: Clinical and Molecular Characterization and Literature Review 254
Should we screen for NAFLD/NASH in HIV patients? 251
Epidemiology and Risk Factors Associated with Mortality in Consecutive Patients with Bacterial Bloodstream Infection: Impact of MDR and XDR Bacteria 250
Not just minor resections: robotic approach for cystic echinococcosis of the liver 249
Two fatal cases of acute liver failure due to HSV-1 infection in COVID-19 patients following immunomodulatory therapies. 247
Long-Term Suppressive Therapeutic-Drug-Monitoring-Guided Dalbavancin Therapy for Cardiovascular Prosthetic Infections 243
Ceftazidime/Avibactam in Ventilator-Associated Pneumonia Due to Difficult-to-Treat Non-Fermenter Gram-Negative Bacteria in COVID-19 Patients: A Case Series and Review of the Literature 240
A proof-of-concept study on the genomic evolution of Sars-Cov-2 in molnupiravir-treated, paxlovid-treated and drug-naïve patients 236
Characteristics of HIV-infected patients not retained in care of two cohorts of northern Italy. 234
Comparison of two perioperative antibiotic schedules in patients undergoing surgical reconstruction with dermal matrix after excision of skin cancer 230
Risk factors for nosocomial rectal colonization with carbapenem-resistant Acinetobacter baumannii in hospital: a matched case–control study 230
Long-Term Impact of the COVID-19 Pandemic on In-Hospital Antibiotic Consumption and Antibiotic Resistance: A Time Series Analysis (2015-2021) 225
Central Nervous System Infections Caused by Bacillus Calmette-Guerin: Case Report and Narrative Literature Review 220
Blackwater Fever Treated with Steroids in Nonimmune Patient, Italy 217
Awaiting a cure for COVID-19: therapeutic approach in patients with different severity levels of COVID-19 214
Association Between Pulmonary Aspergillosis And Cytomegalovirus Reactivation In Critically Ill Covid-19 Patients: A Prospective Observational Cohort Study. 213
Is It Possible to Eradicate Carbapenem-Resistant Acinetobacter baumannii (CRAB) from Endemic Hospitals? 212
Development of post-COVID-19 cardiovascular events: An analysis of clinical features and risk factors from a single hospital retrospective study 211
Breakthrough invasive fungal infection after liver transplantation in patients on targeted antifungal prophylaxis: a prospective multicentre study 205
Real-life experience with compassionate use of cefiderocol for difficult-to-treat resistant Pseudomonas aeruginosa (DTR-P) infections 205
Death After Liver Transplantation: Mining Interpretable Risk Factors for Survival Prediction 204
Pneumocystis jirovecii pneumonia in patients with decompensated cirrhosis: a case series 201
Risk factors for pulmonary air leak and clinical prognosis in patients with COVID-19 related acute respiratory failure: a retrospective matched control study. 201
Do All Critically Ill Patients with COVID-19 Disease Benefit from Adding Tocilizumab to Glucocorticoids? A Retrospective Cohort Study 198
Carbapenemase type and mortality in blood-stream infections caused by carbapenemase-producing enterobacterales: a multicenter retrospective cohort study 197
Incidence, risk factors and outcome of acute kidney injury (AKI) in patients with COVID-19 195
Prospective Study on Incidence, Risk Factors and Outcome of Recurrent Clostridioides difficile Infections 187
AKI in hospitalized patients with COVID-19: a single-center experience 186
Severe acute respiratory syndrome coronavirus 2 infection in patients with hematological malignancies in the Omicron era: Respiratory failure, need for mechanical ventilation and mortality in seronegative and seropositive patients 185
Development of a Risk Prediction Model for Carbapenem-resistant Enterobacteriaceae Infection after Liver Transplantation: A Multinational Cohort Study 183
Prolonged RT-PCR test positivity in hemodialysis patients with COVID-19 180
The WEST Study: A Retrospective and Multicentric Study on the Impact of Steroid Therapy in West Nile Encephalitis 173
Perioperative Use of IgM-Enriched Immunoglobulins in Liver Transplantation Recipients at High Risk for Infections: A Preliminary Study 168
A rare case of necrotizing fasciitis of the leg in an intravenous drug user caused by Prevotella denticola 167
External Validity of a Randomized Controlled Trial on Duration of Antibiotics for the Treatment of Gram-Negative Bacteremia 166
Molecular and cellular immune features of aged patients with severe COVID-19 pneumonia 165
Epidemiology and Prevention of Early Infections by Multi-Drug-Resistant Organisms in Adults Undergoing Liver Transplant: A Narrative Review 164
Impact of VRE-active perioperative prophylaxis in liver transplant patients colonized by Vancomycin-Resistant Enterococci 164
COVID-19 omicron variant outbreak in a hematopoietic stem cell transplant unit 164
Role of Maraviroc in minimizing the risk of graft rejection in HIV-infected kidney transplant recipients 162
Comparison of Patients With or Without COVID-19 and Without Hematological Diseases Treated for Invasive Pulmonary Aspergillosis: A 5-Year Retrospective Cohort Study with Propensity-Based Adjustment 160
Twenty-four-hour serum creatinine variation is associated with poor outcome in the novel coronavirus disease 2019 (COVID-19) patients 160
Risk factors for functional decline among survivors of Gram-negative bloodstream infection: A prospective cohort study 156
A Desirability of Outcome Ranking Analysis of a Randomized Clinical Trial Comparing Seven Versus Fourteen Days of Antibiotics for Uncomplicated Gram-Negative Bloodstream Infection 152
Low-molecular-weight heparin for the prevention of clinical worsening in severe non-critically ill COVID-19 patients: a joint analysis of two randomized controlled trials 152
Reactogenicity of COVID-19 vaccine in hemodialysis patients: a single-center retrospective study 147
Duration of antibiotic treatment for Gram-negative bacteremia - Systematic review and individual participant data (IPD) meta-analysis 145
Efficacy of bezlotoxumab in preventing recurrence of Clostridioides difficile infection: an Italian multicenter cohort study 142
Use of colistin in adult patients: A cross-sectional study 140
Vancomycin resistant enterococcus risk factors for hospital colonization in hematological patients: a matched case-control study 139
First Human Case of Tick-Borne Encephalitis in Non-Endemic Region in Italy: A Case Report 137
The Impact of COVID-19 on UNAIDS 90-90-90 Targets: Calls for New HIV Care Models 134
Persistent SARS-CoV-2 infection with multiple clinical relapses in two patients with follicular lymphoma treated with bendamustine and obinutuzumab or rituximab 127
Distinct leishmania infantum strains circulate in humans and dogs in the Emilia-Romagna region, northeastern Italy 120
Development and validation of a prediction score for failure to casirivimab/imdevimab in hospitalized patients with COVID-19 pneumonia 110
Concomitant Autoimmune Liver Disease and Hepatic Actinomycosis: A Diagnostic Challenge—Brief Report and Review of the Literature 108
Serological and molecular tools to diagnose visceral leishmaniasis: 2-years’ experience of a single center in Northern Italy 88
Streptococcus pneumoniae bacteremia: comparison of incidence, epidemiology, and clinical outcome in a pre- and post-COVID-19 period 84
Monotherapy vs combination therapy for Enterococcus faecalis bacteremia: a target trial emulation 84
Impact of vancomycin resistance on attributable mortality among Enterococcus faecium bloodstream infections: propensity score analysis of a large, multicentre retrospective study 73
Genomic and epidemiological evidence for the emergence of a L. infantum/L. donovani hybrid with unusual epidemiology in northern Italy 58
Totale 24.664
Categoria #
all - tutte 101.170
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 101.170


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.816 141 100 126 79 87 100 205 103 185 146 323 221
2022/20231.969 235 259 176 185 216 244 66 162 187 38 93 108
2023/20241.720 60 93 133 167 295 195 116 178 64 65 130 224
2024/20254.862 144 97 111 323 812 743 415 291 586 235 496 609
2025/202610.325 714 438 783 1.086 1.385 592 1.226 516 981 1.078 882 644
2026/2027442 442 0 0 0 0 0 0 0 0 0 0 0
Totale 24.927